X
FDA approves Sanofi/Regeneron’s Dupixent in asthma
https://pharmaphorum.com/news/fda-approves-sanofi-regenerons-dupixent-in-asthma/
eczema
Sanofi showcases eczema data ahead of EU decision
Dupixent predicted to be blockbuster for Sanofi
Roche sells rights to troubled asthma and eczema drug
Dermira will focus on development in eczema.
Sanofi/Regeneron eczema data paves way for year’s biggest launch
Companies look to take on Pfizer after series of setbacks.
Sanofi’s dermatitis drug dupilumab fast-tracked by FDA
Drug could earn $2.8 billion if approved in AD and asthma
Giving antibiotics to children increases allergy risk
Antibiotics linked with asthma and eczema link.